Arcturus Therapeutics Holdings Inc. financial data

Symbol
ARCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
10628 Science Center Drive, Suite 250, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 399 % +4.71%
Debt-to-equity 56.7 % -4.96%
Return On Equity -26.6 % -185%
Return On Assets -17 % -187%
Operating Margin -54.4 % -427%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27M shares +1.67%
Common Stock, Shares, Outstanding 27M shares +1.76%
Entity Public Float 692M USD +84.1%
Common Stock, Value, Issued 27K USD 0%
Weighted Average Number of Shares Outstanding, Basic 27M shares +1.52%
Weighted Average Number of Shares Outstanding, Diluted 27M shares +1.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 164M USD -38%
Research and Development Expense 200M USD +18.2%
General and Administrative Expense 53.1M USD +3.34%
Operating Income (Loss) -89.1M USD -302%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -70.6M USD -186%
Income Tax Expense (Benefit) 1.37M USD -26.8%
Net Income (Loss) Attributable to Parent -72M USD -190%
Earnings Per Share, Basic -2.69 USD/shares -188%
Earnings Per Share, Diluted -2.65 USD/shares -188%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 260M USD -19.5%
Accounts Receivable, after Allowance for Credit Loss, Current 24.1M USD +760%
Assets, Current 347M USD -9.93%
Property, Plant and Equipment, Net 11.2M USD -12.1%
Operating Lease, Right-of-Use Asset 28.5M USD -6.61%
Assets 389M USD -9.76%
Accounts Payable, Current 13.9M USD +2.1%
Employee-related Liabilities, Current 9.21M USD +5.61%
Accrued Liabilities, Current 35.5M USD +23.2%
Liabilities, Current 91.7M USD +1.52%
Operating Lease, Liability, Noncurrent 27M USD -4.08%
Other Liabilities, Noncurrent 497K USD -82.3%
Liabilities 130M USD -10.6%
Retained Earnings (Accumulated Deficit) -412M USD -21.2%
Stockholders' Equity Attributable to Parent 259M USD -9.33%
Liabilities and Equity 389M USD -9.76%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.56M USD +84.5%
Net Cash Provided by (Used in) Financing Activities 2.19M USD
Net Cash Provided by (Used in) Investing Activities -240K USD +65.3%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 27M shares +1.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.61M USD +94.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 317M USD -16.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.1M USD +1144%
Deferred Tax Assets, Valuation Allowance 109M USD +10.3%
Deferred Tax Assets, Gross 117M USD +9.25%
Operating Lease, Liability 30.9M USD -4.11%
Payments to Acquire Property, Plant, and Equipment 240K USD -65.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -72M USD -190%
Lessee, Operating Lease, Liability, to be Paid 36.8M USD -6.29%
Property, Plant and Equipment, Gross 21.3M USD +7.28%
Operating Lease, Liability, Current 3.92M USD -4.28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.27M USD +31.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.02M USD -11.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.95M USD -16.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.6M USD -10.4%
Deferred Tax Assets, Operating Loss Carryforwards 19.1M USD -60%
Unrecognized Tax Benefits 3.6M USD +24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.71M USD +3%
Additional Paid in Capital 670M USD +7.26%
Share-based Payment Arrangement, Expense 37.6M USD +15.6%